Atherosclerotic cardiovascular disease screening and management protocols among adult HIV clinics in Asia.
Asia
HIV
atherosclerosis
cardiovascular disease
hypertension
Journal
Journal of virus eradication
ISSN: 2055-6640
Titre abrégé: J Virus Erad
Pays: England
ID NLM: 101654142
Informations de publication
Date de publication:
20 Feb 2020
20 Feb 2020
Historique:
entrez:
17
3
2020
pubmed:
17
3
2020
medline:
17
3
2020
Statut:
epublish
Résumé
Integration of HIV and non-communicable disease services improves the quality and efficiency of care in low- and middle-income countries (LMICs). We aimed to describe current practices for the screening and management of atherosclerotic cardiovascular disease (ASCVD) among adult HIV clinics in Asia. Sixteen LMIC sites included in the International Epidemiology Databases to Evaluate AIDS - Asia-Pacific network were surveyed. Sites were mostly (81%) based in urban public referral hospitals. Half had protocols to assess tobacco and alcohol use. Protocols for assessing physical inactivity and obesity were in place at 31% and 38% of sites, respectively. Most sites provided educational material on ASCVD risk factors (between 56% and 75% depending on risk factors). A total of 94% reported performing routine screening for hypertension, 100% for hyperlipidaemia and 88% for diabetes. Routine ASCVD risk assessment was reported by 94% of sites. Protocols for the management of hypertension, hyperlipidaemia, diabetes, high ASCVD risk and chronic ischaemic stroke were in place at 50%, 69%, 56%, 19% and 38% of sites, respectively. Blood pressure monitoring was free for patients at 69% of sites; however, most required patients to pay some or all the costs for other ASCVD-related procedures. Medications available in the clinic or within the same facility included angiotensin-converting enzyme inhibitors (81%), statins (94%) and sulphonylureas (94%). The consistent availability of clinical screening, diagnostic testing and procedures and the availability of ASCVD medications in the Asian LMIC clinics surveyed are strengths that should be leveraged to improve the implementation of cardiovascular care protocols.
Types de publication
Editorial
Langues
eng
Pagination
11-18Subventions
Organisme : NIAID NIH HHS
ID : U01 AI069907
Pays : United States
Informations de copyright
© 2019 The Authors. Journal of Virus Eradication published by Mediscript.
Références
J Acquir Immune Defic Syndr. 2005 Feb 1;38(2):174-9
pubmed: 15671802
Clin Infect Dis. 2010 May 15;50(10):1387-96
pubmed: 20380565
J Epidemiol Glob Health. 2017 Mar;7(1):5-9
pubmed: 27886846
PLoS One. 2014 Mar 14;9(3):e91801
pubmed: 24632720
HIV Med. 2019 Mar;20(3):183-191
pubmed: 30620108
J Acquir Immune Defic Syndr. 2003 Aug 1;33(4):506-12
pubmed: 12869840
Bull World Health Organ. 2007 Nov;85(11):880-5
pubmed: 18038079
J Am Heart Assoc. 2016 Mar 24;4(3):e003411
pubmed: 27013540
BMC Public Health. 2016 Sep 21;16(1):1002
pubmed: 27655406
J Trop Med. 2012;2012:137460
pubmed: 23056058
J Acquir Immune Defic Syndr. 2006 Sep;43(1):27-34
pubmed: 16878047
Int J Epidemiol. 2007 Oct;36(5):969-76
pubmed: 17846055
Circulation. 2019 Jan 8;139(2):180-191
pubmed: 30586710
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
JAMA Intern Med. 2013 Apr 22;173(8):614-22
pubmed: 23459863
J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):590-8
pubmed: 18645512
Health Policy Plan. 2017 Nov 1;32(suppl_4):iv6-iv12
pubmed: 29194541
Int J Epidemiol. 2007 Apr;36(2):294-301
pubmed: 17213214
BMC Health Serv Res. 2015 Sep 23;15:408
pubmed: 26399634
Trop Med Int Health. 2017 Aug;22(8):926-937
pubmed: 28544500
Int J Health Plann Manage. 2014 Apr-Jun;29(2):e159-73
pubmed: 23553675
BMC Infect Dis. 2017 Feb 27;17(1):174
pubmed: 28241797
Int J Epidemiol. 2012 Oct;41(5):1256-64
pubmed: 21593078
Bull World Health Organ. 2011 Aug 1;89(8):547-547A
pubmed: 21836749
Lancet. 2012 Jan 7;379(9810):47-54
pubmed: 22169105
Lancet. 2014 Jul 19;384(9939):241-8
pubmed: 25042234
J Clin Endocrinol Metab. 2007 Jul;92(7):2506-12
pubmed: 17456578